Brief: Nymox Q3 shr loss $0.02
14/11/2014 15:00
Nov 14 (Reuters) - Nymox Pharmaceutical Corp NYMX.O : * Reports third quarter 2014 financial results * Q3 loss per share $0.02 * Says Q3 revenues from sales $81,129 versus $88,888 * Source text for Eikon ID:nGNXVCCDVa * Further company coverage NYMX.O ((Bangalore Newsroom; +1 646 223 8780))
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba